MiR-646 inhibited cell proliferation and migration by targeting P62 in glioma

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
• Aberrant miRNA expression is implicated in various cancers, including glioblastoma (GBM).
• The specific role of miR-646 in GBM pathogenesis remains largely unexplored.

Purpose of the Study:

• To investigate the role of miR-646 in glioblastoma (GBM).
• To elucidate the underlying molecular mechanisms of miR-646 action in GBM.
• To assess the therapeutic potential of miR-646 in GBM.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to measure miR-646 expression levels in GBM tissues.
• In vitro assays (proliferation, invasion, migration) to assess the functional impact of miR-646 overexpression in glioma cells.
• In vivo studies to validate the effects of miR-646 in a GBM model.
• Western blotting and luciferase reporter assays to identify miR-646 targets and signaling pathways involved.

Main Results:

• miR-646 expression was significantly lower in GBM tumor tissues compared to non-cancerous tissues.
• Overexpression of miR-646 suppressed glioma cell proliferation, invasion, and migration both in vitro and in vivo.
• Mechanistically, miR-646 was found to directly target sequestosome 1 (p62) in the 3' untranslated region (3'UTR).
• miR-646 affected the Keap1/Nrf2 pathway, leading to the attenuation of heme oxygenase-1 (HO-1) gene expression.

Conclusions:

• miR-646 plays a tumor-suppressive role in glioblastoma (GBM).
• miR-646 inhibits gliomagenesis by regulating the p62/Keap1/Nrf2/HO-1 axis.
• miR-646 represents a potential novel therapeutic target for GBM treatment.